Faculty of Medicine and Health
Executive Dean announcement
Professor Mark Kearney has been appointed Executive Dean of the Faculty of Medicine and Health (FMH). Having held the post in an interim capacity since March 2021, Professor Kearney will take up the role with immediate effect.
Find out about his vision for the future of FMH
Welcome from the Executive Dean
Here at Leeds we pride ourselves on our dynamic and innovative clinical and academic educational portfolio. We offer a range of education, research and training opportunities in world-class facilities. Leeds is a great place to study and we welcome students from across the globe to study with us.
Our schools are consistently highly ranked, nationally and internationally, and have maintained a global reputation for academic excellence, world-class research and technology-enhanced learning. Our acclaimed strength in both teaching and research attracts the best clinicians and academics to work with us.
Equality and Inclusion
The Faculty is committed to creating an inclusive working environment for all our staff and students.
The Faculty Equality and Inclusion committee meets termly and works closely with the University Equality Policy Unit to promote the University Equality Objectives.
World top 100 University
QS World Rankings 2022
Good University Guide 2021
in research income
Research and innovation
Across our four schools we undertake leading research to drive forward understanding within our fields, whilst improving the provision of care and delivering meaningful impact for our partners and collaborators. This is enabled by world-renowned research staff and state-of-the-art facilities. Our vision is to apply our research, education and practice to improve health outcomes and quality of life for individuals and societies.
Survey highlights the benefit of physical and mathematical sciences, new…
Thursday 26 January 2023More on New research reveals progress in Neurodegenerative disease approaches
Giving colon cancer patients chemotherapy before surgery cuts the risk of the…
Monday 23 January 2023More on 'Remarkable' results in colon cancer trial
New Lancet Rheumatology paper shows low risk of severe outcomes from Rituximab use for patients who receive COVID and Booster vaccination
Patients taking an immunosuppressant drug for rheumatic and musculoskeletal…
Thursday 12 January 2023More on New Lancet Rheumatology paper shows low risk of severe outcomes from Rituximab use for patients who receive COVID and Booster vaccination
New research has identified a genetic marker that could be used to predict a…
Monday 9 January 2023More on Scientists find genetic ‘marker’ linked to serious side-effects from skin cancer treatment